Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate
4 NDCs across 1 manufacturer|0 Generic,4 Brand
▸ More about this market▾ Less
Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate is available as 4 NDCs from 1 manufacturer (0 generic, 4 brand), with NADAC prices from $11.09 to $11.20 per EA — a 1% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
4
0G / 4B
Manufacturers
1
competing in market
Price Spread
$11.09 – $11.20
per EA
7d Activity
avg -0.0% WoW · of 4 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
TRELEGY ELLIPTA 200-62.5-25 | $11.2033 per EA | 0.00% |
TRELEGY ELLIPTA 200-62.5-25 | $11.1531 per EA | -0.03% |
TRELEGY ELLIPTA 100-62.5-25 | $11.1524 per EA | -0.03% |
TRELEGY ELLIPTA 100-62.5-25 | $11.0919 per EA | 0.00% |
Frequently Asked Questions
How many Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate products are on the market?
The Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate drug market contains 4 NDCs from 1 manufacturer — 0 generic and 4 brand products.
What is the price range for Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate?
NADAC reference prices for Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate range from $11.0919 to $11.2033 per EA — a 1% difference between cheapest and most expensive.
Which manufacturers make Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate?
1 manufacturer lists Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate in NADAC. Ranked by number of NDCs, the largest are GlaxoSmithKline LLC (4).
How has the price of Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate changed recently?
Over the past 7 days, 0 Fluticasone Furoate, Umeclidinium Bromide and Vilanterol Trifenatate NDCs rose and 6 fell, with a market-wide average change of -0.0%.